102 related articles for article (PubMed ID: 23952654)
1. Malignant potential of small oncocytic follicular carcinoma/Hürthle cell carcinoma: an institutional experience.
Samulski TD; Bai S; LiVolsi VA; Montone K; Baloch Z
Histopathology; 2013 Oct; 63(4):568-73. PubMed ID: 23952654
[TBL] [Abstract][Full Text] [Related]
2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
3. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
5. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
Yang GC; Schreiner AM; Sun W
Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
[TBL] [Abstract][Full Text] [Related]
6. Thyroid bed fine needle aspiration in patients after thyroidectomy--a useful follow-up tool with proposed diagnostic categories.
Webster N; Fox C; Fan F
Ann Diagn Pathol; 2014 Jun; 18(3):177-80. PubMed ID: 24768495
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
[TBL] [Abstract][Full Text] [Related]
8. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
9. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
Samulski TD; Livolsi VA; Montone K; Baloch Z
Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
[TBL] [Abstract][Full Text] [Related]
10. Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases.
Bongiovanni M; Uccella S; Giovanella L; Molinari F; Frattini M; Dionigi G; Piantanida E; Nobile A; Sessa F; La Rosa S
Endocr Pathol; 2016 Dec; 27(4):338-345. PubMed ID: 27108352
[TBL] [Abstract][Full Text] [Related]
11. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
[TBL] [Abstract][Full Text] [Related]
12. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland.
Bishop JA; Wu G; Tufano RP; Westra WH
Thyroid; 2012 Jul; 22(7):690-4. PubMed ID: 22524498
[TBL] [Abstract][Full Text] [Related]
13. The oncocyte that went places: diagnosis with EUS-guided FNA.
Safdar Khan A; Crowe DR; Eloubeidi MA
Diagn Cytopathol; 2013 Nov; 41(11):977-9. PubMed ID: 21954063
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies.
Adhikari LJ; Sciallis AP; Reynolds J; Jenkins S; Smith C; Stan MN; Nassar A
Thyroid; 2013 Aug; 23(8):982-8. PubMed ID: 23374006
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid.
Wu HH; Clouse J; Ren R
Diagn Cytopathol; 2008 Mar; 36(3):149-54. PubMed ID: 18232004
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules.
Lee KH; Shin JH; Ko ES; Hahn SY; Kim JS; Kim JH; Oh YL
Int J Surg; 2013; 11(9):898-902. PubMed ID: 23916366
[TBL] [Abstract][Full Text] [Related]
19. Hürthle cell tumors of the thyroid gland. Personal experience and review of literature.
Bononi M; De Cesare A; Cangemi V; Fiori E; Galati G; Giovagnoli MR; Izzo L; Cimitan A; Meucci M; Cavallaro A
Anticancer Res; 2002; 22(6B):3579-82. PubMed ID: 12552959
[TBL] [Abstract][Full Text] [Related]
20. [Follicular carcinoma and Hürthle cell tumor of the thyroid].
Miccoli P; Arganini M
Chir Ital; 1994; 46(4):29-32. PubMed ID: 7882439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
